Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) EBT Margin (2016 - 2025)

STRATA Skin Sciences' EBT Margin history spans 13 years, with the latest figure at 14.35% for Q3 2025.

  • For Q3 2025, EBT Margin rose 923.0% year-over-year to 14.35%; the TTM value through Sep 2025 reached 12.83%, up 1863.0%, while the annual FY2024 figure was 30.56%, 218.0% up from the prior year.
  • EBT Margin for Q3 2025 was 14.35% at STRATA Skin Sciences, up from 33.6% in the prior quarter.
  • Across five years, EBT Margin topped out at 14.71% in Q2 2021 and bottomed at 49.84% in Q1 2024.
  • The 5-year median for EBT Margin is 20.78% (2022), against an average of 19.76%.
  • The largest annual shift saw EBT Margin tumbled -4381bps in 2023 before it soared 5757bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 9.13% in 2021, then surged by 90bps to 0.91% in 2022, then crashed by -4788bps to 44.72% in 2023, then surged by 129bps to 12.84% in 2024, then plummeted by -212bps to 14.35% in 2025.
  • Per Business Quant, the three most recent readings for SSKN's EBT Margin are 14.35% (Q3 2025), 33.6% (Q2 2025), and 24.02% (Q1 2025).